Christophe Laurent1,2, Jean-Philippe Adam3,4, Quentin Denost3,4, Denis Smith3,5, Jean Saric3,4, Laurence Chiche3,6. 1. University of Bordeaux Segalen, 33076, Bordeaux, France. christophe.laurent@chu-bordeaux.fr. 2. Department of Hepatobiliary Surgery, CHU Bordeaux, Saint André Hospital, 1 rue Jean Burguet, 33075, Bordeaux, France. christophe.laurent@chu-bordeaux.fr. 3. University of Bordeaux Segalen, 33076, Bordeaux, France. 4. Department of Hepatobiliary Surgery, CHU Bordeaux, Saint André Hospital, 1 rue Jean Burguet, 33075, Bordeaux, France. 5. Department of Digestive Oncology, CHU Bordeaux, Saint André Hospital, 33075, Bordeaux, France. 6. Department of Hepatobiliary Surgery, CHU Bordeaux, Haut-Lévèque Hospital, 33600, Pessac, France.
Abstract
BACKGROUND: The prognosis impact of positive margins after resection of colorectal liver metastases (CLM) in patients treated with modern effective chemotherapy has not been elucidated. The objective was to compare oncologic outcomes after R0 and R1 resections in the era of modern effective chemotherapy. METHODS: Between 1999 and 2010, all consecutive patients undergoing liver resection for CLM were analyzed retrospectively. Patients with extrahepatic metastases, macroscopic residual tumor, treated with combined radiofrequency, or not treated with chemotherapy were excluded. Survival and recurrence after R0 (tumor-free margin >0 mm) and R1 resections were analyzed. RESULTS: Among 466 patients undergoing hepatectomy for CLM, 191 were eligible. Of them, 164 (86 %) received preoperative chemotherapy and 105 (55 %) received postoperative chemotherapy. R1 resection (10 %) was comparable in patients treated or not by preoperative chemotherapy. R1 status was associated with more intrahepatic recurrences. Overall survival (OS) (44 vs. 61 %; p = 0.047) and disease-free survival (DFS) (8 vs. 26 %; p = 0.082) were lower in patients after R1 compared to R0 resection (32 months of median follow-up). Preoperative chemotherapy and major hepatectomy were prognostic factors of survival, whereas postoperative chemotherapy was a protective factor from recurrences. In patients treated with preoperative chemotherapy, OS and DFS were similar between R1 and R0 resections (40 vs. 55 %, p = 0.104 and 9 vs. 22 %, p = 0.174, respectively). CONCLUSION: In the era of modern effective chemotherapy, R1 resection leads to more intrahepatic recurrences but did not affect OS in selected patient responders to neoadjuvant chemotherapy. Postoperative chemotherapy protects from recurrences whatever the margin resection status.
BACKGROUND: The prognosis impact of positive margins after resection of colorectal liver metastases (CLM) in patients treated with modern effective chemotherapy has not been elucidated. The objective was to compare oncologic outcomes after R0 and R1 resections in the era of modern effective chemotherapy. METHODS: Between 1999 and 2010, all consecutive patients undergoing liver resection for CLM were analyzed retrospectively. Patients with extrahepatic metastases, macroscopic residual tumor, treated with combined radiofrequency, or not treated with chemotherapy were excluded. Survival and recurrence after R0 (tumor-free margin >0 mm) and R1 resections were analyzed. RESULTS: Among 466 patients undergoing hepatectomy for CLM, 191 were eligible. Of them, 164 (86 %) received preoperative chemotherapy and 105 (55 %) received postoperative chemotherapy. R1 resection (10 %) was comparable in patients treated or not by preoperative chemotherapy. R1 status was associated with more intrahepatic recurrences. Overall survival (OS) (44 vs. 61 %; p = 0.047) and disease-free survival (DFS) (8 vs. 26 %; p = 0.082) were lower in patients after R1 compared to R0 resection (32 months of median follow-up). Preoperative chemotherapy and major hepatectomy were prognostic factors of survival, whereas postoperative chemotherapy was a protective factor from recurrences. In patients treated with preoperative chemotherapy, OS and DFS were similar between R1 and R0 resections (40 vs. 55 %, p = 0.104 and 9 vs. 22 %, p = 0.174, respectively). CONCLUSION: In the era of modern effective chemotherapy, R1 resection leads to more intrahepatic recurrences but did not affect OS in selected patient responders to neoadjuvant chemotherapy. Postoperative chemotherapy protects from recurrences whatever the margin resection status.
Authors: P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther Journal: J Natl Cancer Inst Date: 2000-02-02 Impact factor: 13.506
Authors: Mehrdad Nikfarjam; Serene Shereef; Eric T Kimchi; Niraj J Gusani; Yixing Jiang; Diego M Avella; Rickhesvar P Mahraj; Kevin F Staveley-O'Carroll Journal: Ann Surg Oncol Date: 2008-11-27 Impact factor: 5.344
Authors: B Cady; R L Jenkins; G D Steele; W D Lewis; M D Stone; W V McDermott; J M Jessup; A Bothe; P Lalor; E J Lovett; P Lavin; D C Linehan Journal: Ann Surg Date: 1998-04 Impact factor: 12.969
Authors: Y Fong; A M Cohen; J G Fortner; W E Enker; A D Turnbull; D G Coit; A M Marrero; M Prasad; L H Blumgart; M F Brennan Journal: J Clin Oncol Date: 1997-03 Impact factor: 44.544
Authors: K S Hughes; R Simon; S Songhorabodi; M A Adson; D M Ilstrup; J G Fortner; B J Maclean; J H Foster; J M Daly; D Fitzherbert Journal: Surgery Date: 1986-08 Impact factor: 3.982
Authors: Frank Makowiec; Peter Bronsert; Andrea Klock; Ulrich T Hopt; Hannes P Neeff Journal: Int J Colorectal Dis Date: 2017-11-02 Impact factor: 2.571
Authors: Jonah Popp; David S Weinberg; Eva Enns; John A Nyman; J Robert Beck; Karen M Kuntz Journal: Value Health Date: 2021-10-13 Impact factor: 5.101
Authors: Cynthia L Miller; Martin S Taylor; Motaz Qadan; Vikram Deshpande; Steven Worthington; Robert Smalley; Chey Collura; David P Ryan; Jill N Allen; Lawrence S Blaszkowsky; Jeffrey W Clark; Janet E Murphy; Aparna R Parikh; David Berger; Kenneth K Tanabe; Keith D Lillemoe; Cristina R Ferrone Journal: J Gastrointest Surg Date: 2017-09-07 Impact factor: 3.452
Authors: Wong Hoi She; Tan To Cheung; Ka Wing Ma; Simon H Y Tsang; Wing Chiu Dai; Albert C Y Chan; Chung Mau Lo Journal: Langenbecks Arch Surg Date: 2021-05-22 Impact factor: 3.445
Authors: Mariana I Chavez; Sepideh Gholami; Bradford J Kim; Georgios A Margonis; Cecilia G Ethun; Susan Tsai; Kathleen K Christians; Callisia Clarke; Harveshp Mogal; Shishir K Maithel; Timothy M Pawlik; Michael I D'Angelica; Thomas A Aloia; Daniel Eastwood; T Clark Gamblin Journal: Ann Surg Oncol Date: 2021-01-03 Impact factor: 5.344